Should We Screen Patients With HIV for NAFLD/NASH?

In this episode, hepatologist Giada Sebastiani, MD, discusses why the presence of obesity, metabolic syndrome, persistent elevation of ALT, or exposure to dideoxynucleoside analogues can trigger an evaluation for NAFLD and NASH, particularly in our aging population of patients with HIV with topics including:

• Metabolic factors  
• HIV-related factors
• Which patients with HIV are at risk

Presenter:

Giada Sebastiani, MD
Associate Professor of Medicine
McGill University Health Centre
Division of Gastroenterology and Hepatology and Division of Infectious Diseases
Clinician Scientist
Research Institute of McGill University Health Centre
Montreal, Quebec, Canada

Content based on an online CME program supported by an educational grant from Theratechnologies Inc.

Link to full program: 
https://bit.ly/3BYoXBP

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.